Of the total 1,853,866 eligible adults identified, 27,704 patients were dispensed sodium polystyrene sulfonate (average [SD] age: 78.5 [7.7] years; 54.7% male); 20,020 users of sodium polystyrene ...

Between 14 and 16 hours after administration of sodium polystyrene sulfonate, researchers observed a median serum potassium decrease of 0.8 mEq/L after a 30-gram dose and a median decrease of 0.7 ...

Sodium polystyrene sulfonate (SPS) has been commonly prescribed to treat hyperkalemia since its approval in 1959. Now new evidence published online ahead of print in JAMA Internal Medicine links ...

Sodium Polystyrene Sulfonate(Kayexalate) generic is a potassium-removing resin, prescribed for hyperkalemia (without ECG changes). It affects the exchange of sodium and potassium in the body. More ...

Sodium Polystyrene Sulfonate Shows Little Benefit for Hyperkalemia In patients with mild hyperkalemia, oral SPS therapy reduced serum potassium by just 0.14 mmol/L more than control.

Journal of Perinatology - Successful Treatment of Sodium PolyStyrene Sulfonate Bezoars With Serial Water-Soluble Contrast Enemas Skip to main content Thank you for visiting nature.com.

ANI Pharmaceuticals announced the launch of Kionex ® (sodium polystyrene sulfonate suspension USP) for Oral or Rectal Use for the treatment of hyperkalemia. The product is therapeutically ...

However, it’s still available as a generic version: sodium polystyrene sulfonate. The only side effect that Lokelma appears to share with this drug is allergic reaction .

Cecal perforation associated with sodium polystyrene sulfonate-sorbitol enemas in a 650 gram infant with hyperkalemia. Am J Perinatol 1996; 13: 167–170. Article CAS Google Scholar ...